Bioventus Inc. (BVS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:26PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 382.33M |
| Enterprise value | 748.40M |
| Trailing P/E | N/A |
| Forward P/E | 22.17 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.72 |
| Price/book (mrq) | 2.23 |
| Enterprise value/revenue | 1.43 |
| Enterprise value/EBITDA | 11.01 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.50 |
| 52-week change 3 | 357.25% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 6.31 |
| 52-week low 3 | 1.12 |
| 50-day moving average 3 | 4.93 |
| 200-day moving average 3 | 4.27 |
Share statistics
| Avg vol (3-month) 3 | 226.46k |
| Avg vol (10-day) 3 | 612.16k |
| Shares outstanding 5 | 63.83M |
| Implied shares outstanding 6 | 63.83M |
| Float 8 | 23.52M |
| % held by insiders 1 | 11.08% |
| % held by institutions 1 | 66.19% |
| Shares short (15 Apr 2024) 4 | 891.04k |
| Short ratio (15 Apr 2024) 4 | 5.67 |
| Short % of float (15 Apr 2024) 4 | 2.05% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.40% |
| Shares short (prior month 15 Mar 2024) 4 | 808.24k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -30.49% |
| Operating margin (ttm) | 1.91% |
Management effectiveness
| Return on assets (ttm) | 0.12% |
| Return on equity (ttm) | -38.27% |
Income statement
| Revenue (ttm) | 512.34M |
| Revenue per share (ttm) | 8.18 |
| Quarterly revenue growth (yoy) | 7.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 28.85M |
| Net income avi to common (ttm) | -96.74M |
| Diluted EPS (ttm) | -1.54 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 36.96M |
| Total cash per share (mrq) | 0.58 |
| Total debt (mrq) | 420.62M |
| Total debt/equity (mrq) | 190.23% |
| Current ratio (mrq) | 1.53 |
| Book value per share (mrq) | 2.74 |
Cash flow statement
| Operating cash flow (ttm) | 15.34M |
| Levered free cash flow (ttm) | -108.45M |
© 2024 Yahoo. All rights reserved.